EverEx partners with Xenco Medical to accelerate US market entry

EverEx, a musculoskeletal digital healthcare company, said Monday that it has signed an agreement with California-based Xenco Medical to supply its rehabilitation exercise telemedicine monitoring solution, EverEx Rehab, in the U.S. market.

Xenco Medical, which designs, develops, and distributes composite polymer surgical devices, serves over 400 hospitals across the U.S., including those in California. Through this partnership, EverEx will leverage Xenco Medical’s supply chain to offer EverEx Rehab to specialists, enhancing its presence in the U.S. telemedicine market for rehabilitation exercises.

EverEx Rehab, a teletherapy monitoring solution, enables healthcare providers to remotely oversee rehabilitation exercises for patients. It became Korea’s first U.S. FDA Class 2 medical device in July 2023. The solution also qualifies for reimbursement under the Remote Therapeutic Monitoring (RTM) CPT code, introduced in 2022, allowing public and private insurers, including Medicare, to cover its use.

EverEx Rehab is currently being piloted in physical therapy centers and hospitals through EverEx’s U.S. subsidiary. The collaboration with Xenco Medical aims to further local commercialization, focusing on expanding distribution to orthopedic and neurosurgery hospitals.

EverEx participated in the California Physical Therapy Association (CPTA) Annual Conference on Sept. 21-22, introducing its EverEx Rehab solution to U.S. physical therapists and hospital officials. The company will also attend the American Physical Therapy Association (APTA) Private Practice Annual Conference from Wednesday to Saturday for business meetings and outreach. The APTA Private Practice Conference brings together around 4,000 U.S.-based physical therapists to discuss business strategies and marketing approaches.

“We are excited to expand the use of our technology in U.S. physical therapy centers and orthopedic and neurosurgical hospitals through our collaboration with Xenco Medical,” an EverEx representative said. “The recent introduction of telehealth monitoring in the U.S. is a promising opportunity, and we believe our unique AI posture estimation technology, along with our evidence-based rehabilitation exercise curriculum, positions us to take a leadership role in this emerging market.”

EverEx currently offers four core solutions under its AI-driven digital therapeutics (DTx) software brand, Mobile Orthopedic Rehabilitation Assistant (MORA): MORA Ex, a remote rehabilitation exercise platform; MORA Vu, AI-powered motion analysis software; MORA Cure, a digital therapeutic device for musculoskeletal conditions; and MORA Care, a health management solution focused on employee musculoskeletal wellness.